Xiaojiang Fang

No. 453 Stadium Road
Hangzhou, 310007, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

SULF1 and EPB41L3: Potential Biomarkers of Acute Myocardial Infarction and the Vascular Inflammatory Milieu.

SULF1 and EPB41L3: Potential Biomarkers of Acute Myocardial Infarction and the Vascular Inflammatory Milieu.

Journal: Journal of inflammation research

Published: January 13, 2026

Association of inflammatory risk based on the Glasgow Prognostic Score with long-term mortality in patients with cardiovascular disease.

Association of inflammatory risk based on the Glasgow Prognostic Score with long-term mortality in patients with cardiovascular disease.

Journal: Scientific reports

Published: May 13, 2024

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials.

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials.

Journal: Frontiers in cardiovascular medicine

Published: September 09, 2022

The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective.

The Importance of Integrated Regulation Mechanism of Coronary Microvascular Function for Maintaining the Stability of Coronary Microcirculation: An Easily Overlooked Perspective.

Journal: Advances in therapy

Published: August 25, 2022

Efficacy and Safety of Long-Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.

Efficacy and Safety of Long-Term Antithrombotic Strategies in Patients With Chronic Coronary Syndrome: A Network Meta-analysis of Randomized Controlled Trials.

Journal: Journal of the American Heart Association

Published: March 08, 2021

Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.

Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.

Journal: PeerJ

Published: January 24, 2020

Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials".

Response to Letter Regarding Article, "Effects of the Antianginal Drugs Ranolazine, Nicorandil and Ivabradine on Coronary Microvascular Function in Patients with Non-obstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials".

Journal: Clinical therapeutics

Published: December 22, 2019

Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.

Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.

Journal: Clinical therapeutics

Published: June 05, 2019

Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.

Effects of mitochondrial ATP-sensitive potassium channel activation (nicorandil) in patients with angina pectoris undergoing elective percutaneous coronary interventions: A meta-analysis of randomized controlled trials.

Journal: Medicine

Published: January 18, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026